Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model”
Yanlan Fang, Hong Chen, Chunlin Wang, et al.
World Journal of Gastroenterology (2018) Vol. 24, Iss. 27, pp. 2974-2983
Open Access | Times Cited: 325

Showing 26-50 of 325 citing articles:

Validation of an adipose-liver human-on-a-chip model of NAFLD for preclinical therapeutic efficacy evaluation
Victoria L. Slaughter, John W. Rumsey, Rachel Boone, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 48
From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?
Marta Flisiak‐Jackiewicz, Anna Bobrus‐Chociej, Natalia Wasilewska, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 5, pp. 924-924
Open Access | Times Cited: 42
Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma
Xinhe Zhang, Lin Guan, Haoyu Tian, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 42
The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review
Seyedeh Alia Moosavian, Thozhukat Sathyapalan, Tannaz Jamialahmadi, et al.
Bioinorganic Chemistry and Applications (2021) Vol. 2021, pp. 1-13
Open Access | Times Cited: 42
Effect of Probiotics Therapy on Nonalcoholic Fatty Liver Disease
Yuanshe Huang, Xiaodong Wang, Lai Zhang, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 33
Roles of hepatic stellate cells in NAFLD: From the perspective of inflammation and fibrosis
Man Wang, Lei Li, Yannan Xu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 32
Wnt/beta‐catenin signaling and its modulators in nonalcoholic fatty liver diseases
Karthik Shree Harini, Devaraj Ezhilarasan
Hepatobiliary & pancreatic diseases international (2022) Vol. 22, Iss. 4, pp. 333-345
Closed Access | Times Cited: 31
Melatonin Suppresses NLRP3 Inflammasome Activation via TLR4/NF-κB and P2X7R Signaling in High-Fat Diet-Induced Murine NASH Model
Moumita Saha, Krishnendu Manna, Krishna Das Saha
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 3235-3258
Open Access | Times Cited: 30
Mediterranean Diet: The Beneficial Effects of Lycopene in Non-Alcoholic Fatty Liver Disease
Ludovico Abenavoli, Anna Caterina Procopio, Maria Rosaria Paravati, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 12, pp. 3477-3477
Open Access | Times Cited: 29
Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD)
Qin Guo, Yun Li, Xin Dai, et al.
Nutrients (2023) Vol. 15, Iss. 17, pp. 3722-3722
Open Access | Times Cited: 21
Metabolic dysfunction: The silenced connection with fatty liver disease
Mariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, et al.
Annals of Hepatology (2023) Vol. 28, Iss. 6, pp. 101138-101138
Open Access | Times Cited: 20
Atractylodin alleviates nonalcoholic fatty liver disease by regulating Nrf2-mediated ferroptosis
Qing-Yan Ye, Yun Jiang, Di Wu, et al.
Heliyon (2023) Vol. 9, Iss. 7, pp. e18321-e18321
Open Access | Times Cited: 18
Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics
Gary Huang, Daniel F. Wallace, Elizabeth E. Powell, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2809-2809
Open Access | Times Cited: 17
Extracellular vesicle therapy for obesity-induced NAFLD: a comprehensive review of current evidence
Jiali Zhang, Baochen Ma, Zixu Wang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Single-cell transcriptome landscape of zebrafish liver reveals hepatocytes and immune cell interactions in understanding nonalcoholic fatty liver disease
Yingyi Huang, Xiang Liu, Hongyan Wang, et al.
Fish & Shellfish Immunology (2024) Vol. 146, pp. 109428-109428
Open Access | Times Cited: 8
Lead exposure exacerbates liver injury in high-fat diet-fed mice by disrupting the gut microbiota and related metabolites
Nana Wang, Yuan Huo, Xue Gao, et al.
Food & Function (2024) Vol. 15, Iss. 6, pp. 3060-3075
Closed Access | Times Cited: 8
The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation
Ludovico Abenavoli, Maria Luisa Gambardella, Giuseppe Guido Maria Scarlata, et al.
Medicina (2024) Vol. 60, Iss. 4, pp. 563-563
Open Access | Times Cited: 8
Effect of Tetrastigma hemsleyanum leaves and Extract supplementation on liver metabolomics and the gut microbiota in alcohol-induced liver injury
Kexin Tao, Han Peng, Xin Bi, et al.
Food Bioscience (2024) Vol. 58, pp. 103617-103617
Closed Access | Times Cited: 7
Dietary glycine supplementation enhances glutathione availability in tissues of pigs with intrauterine growth restriction
Wenliang He, Erin A Posey, Chandler C Steele, et al.
Journal of Animal Science (2024) Vol. 102
Closed Access | Times Cited: 7
Oxidative Stress as a Target for Non-Pharmacological Intervention in MAFLD: Could There Be a Role for EVOO?
Aurelio Seidita, Alessandra Cusimano, Alessandra Giuliano, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 731-731
Open Access | Times Cited: 7
Current perspectives on mesenchymal stem cells as a potential therapeutic strategy for non-alcoholic fatty liver disease
Yan Jiang, Narazah Mohd Yusoff, Jiang Du, et al.
World Journal of Stem Cells (2024) Vol. 16, Iss. 7, pp. 760-772
Open Access | Times Cited: 7
Silybin ameliorates hepatic lipid accumulation and modulates global metabolism in an NAFLD mouse model
Runbin Sun, Dan Xu, Qingli Wei, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 123, pp. 109721-109721
Open Access | Times Cited: 53
The Gut Microbiota and Its Metabolites, Novel Targets for Treating and Preventing Non‐Alcoholic Fatty Liver Disease
Yinhua Ni, Liyang Ni, Fen Zhuge, et al.
Molecular Nutrition & Food Research (2020) Vol. 64, Iss. 17
Closed Access | Times Cited: 46
Mechanistic study of attenuation of monosodium glutamate mixed high lipid diet induced systemic damage in rats by Coccinia grandis
Arnab Banerjee, Debasmita Das, Rajarshi Paul, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 46
Can You Trust Your Gut? Implicating a Disrupted Intestinal Microbiome in the Progression of NAFLD/NASH
Kavita Jadhav, Taylor S. Cohen
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 45

Scroll to top